Adrienn Krauszman1,2, Tak W Mak3, Katalin Szaszi1,4, Wolfgang M Kuebler1,2,4,5. 1. Department of Surgery, The Keenan Research Centre for Biomedical Science at St. Michael's Hospital, 209 Victoria Street, M5B 1T8, Toronto, ON, Canada. 2. Department of Physiology, Institute of Physiology, Charité - Universitaetsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany. 3. Departments of Medical Biophysics and Immunology, Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, 620 University Ave, M5G 2C1, Toronto, ON, Canada. 4. Department of Surgery. 5. Department of Physiology, University of Toronto, 27 King's College Circle, M5S 1A1, Toronto, ON, Canada.
Abstract
AIMS: Hypoxic pulmonary vasoconstriction (HPV) redistributes blood flow from poorly ventilated to better aerated areas in the lung, thereby optimizing ventilation-perfusion ratio (V/Q). Pulmonary artery smooth muscle cell (PASMC) contraction in response to hypoxia is triggered by Ca2+ influx via transient receptor potential canonical 6 (TRPC6) cation channels that have translocated to caveolae in the plasma membrane. Since phosphatase and tensin homolog (PTEN) was suggested to regulate TRPC6 in endothelial cells, we aimed to define its role in the hypoxic response of PASMCs and as a putative mediator of HPV. METHODS AND RESULTS: In isolated perfused mouse lungs, smooth muscle specific PTEN deficiency attenuated pulmonary vasoconstriction in response to hypoxia but not to angiotensin II (Ang II). Analogously, siRNA-mediated knock down of PTEN in human PASMC inhibited the hypoxia-induced increase in cytosolic Ca2+ concentration ([Ca2+]i). Co-immunoprecipitation and proximity ligation assays revealed increased interaction of PTEN with TRPC6 in human PASMC and murine lungs in response to hypoxia. In hypoxic PASMC, both PTEN and TRPC6 translocated to caveolae, and this response was blocked by pharmacological inhibition of Rho-associated protein kinase (ROCK) which in parallel prevented PTEN-TRPC6 interaction, hypoxia-induced [Ca2+]i increase, and HPV in PASMC and murine lungs, respectively. CONCLUSION: Our data indicate a novel interplay between ROCK and [Ca2+]i signalling in HPV via PTEN, in that ROCK mediates interaction of PTEN and TRPC6 which then conjointly translocate to caveolae allowing for Ca2+ influx into and subsequent contraction of PASMC. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Hypoxic pulmonary vasoconstriction (HPV) redistributes blood flow from poorly ventilated to better aerated areas in the lung, thereby optimizing ventilation-perfusion ratio (V/Q). Pulmonary artery smooth muscle cell (PASMC) contraction in response to hypoxia is triggered by Ca2+ influx via transient receptor potential canonical 6 (TRPC6) cation channels that have translocated to caveolae in the plasma membrane. Since phosphatase and tensin homolog (PTEN) was suggested to regulate TRPC6 in endothelial cells, we aimed to define its role in the hypoxic response of PASMCs and as a putative mediator of HPV. METHODS AND RESULTS: In isolated perfused mouse lungs, smooth muscle specific PTEN deficiency attenuated pulmonary vasoconstriction in response to hypoxia but not to angiotensin II (Ang II). Analogously, siRNA-mediated knock down of PTEN in human PASMC inhibited the hypoxia-induced increase in cytosolic Ca2+ concentration ([Ca2+]i). Co-immunoprecipitation and proximity ligation assays revealed increased interaction of PTEN with TRPC6 in human PASMC and murine lungs in response to hypoxia. In hypoxic PASMC, both PTEN and TRPC6 translocated to caveolae, and this response was blocked by pharmacological inhibition of Rho-associated protein kinase (ROCK) which in parallel prevented PTEN-TRPC6 interaction, hypoxia-induced [Ca2+]i increase, and HPV in PASMC and murine lungs, respectively. CONCLUSION: Our data indicate a novel interplay between ROCK and [Ca2+]i signalling in HPV via PTEN, in that ROCK mediates interaction of PTEN and TRPC6 which then conjointly translocate to caveolae allowing for Ca2+ influx into and subsequent contraction of PASMC. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Neil M Goldenberg; Liming Wang; Hannes Ranke; Wolfgang Liedtke; Arata Tabuchi; Wolfgang M Kuebler Journal: Anesthesiology Date: 2015-06 Impact factor: 7.892
Authors: Y Kanamori; J Kigawa; H Itamochi; M Shimada; M Takahashi; S Kamazawa; S Sato; R Akeshima; N Terakawa Journal: Clin Cancer Res Date: 2001-04 Impact factor: 12.531
Authors: N Sommer; A Dietrich; R T Schermuly; H A Ghofrani; T Gudermann; R Schulz; W Seeger; F Grimminger; N Weissmann Journal: Eur Respir J Date: 2008-12 Impact factor: 16.671
Authors: M Takata; H Tanaka; M Kimura; Y Nagahara; K Tanaka; K Kawasaki; M Seto; K Tsuruma; M Shimazawa; H Hara Journal: Br J Pharmacol Date: 2013-09 Impact factor: 8.739
Authors: Benjamin Keserü; Eduardo Barbosa-Sicard; Rüdiger Popp; Beate Fisslthaler; Alexander Dietrich; Thomas Gudermann; Bruce D Hammock; John R Falck; Norbert Weissmann; Rudi Busse; Ingrid Fleming Journal: FASEB J Date: 2008-08-25 Impact factor: 5.191
Authors: Henrick Horita; Seth B Furgeson; Allison Ostriker; Kyle A Olszewski; Timothy Sullivan; Leah R Villegas; Michelle Levine; Jane E Parr; Carlyne D Cool; Raphael A Nemenoff; Mary C M Weiser-Evans Journal: J Am Heart Assoc Date: 2013-05-31 Impact factor: 5.501